School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.
J Immunol. 2011 Jan 1;186(1):499-507. doi: 10.4049/jimmunol.0903534. Epub 2010 Nov 24.
Toll/IL-1R domain-containing adaptor inducing IFN-β (TRIF) is an adaptor molecule that is recruited to TLR3 and -4 upon agonist stimulation and triggers activation of IFN regulatory factor 3 (IRF3) and expression of type 1 IFNs, which are critical for cellular antiviral responses. We show that Akt is a downstream molecule of TRIF/TANK-binding kinase 1 (TBK1) and plays an important role in the activation of IRF3 by TLR3 and -4 agonists. Blockade of Akt by a dominant-negative mutant or by short interfering RNA decreased IRF3 activation and IFN-β expression induced by polyinosinic:polycytidylic acid [poly(I:C)], LPS, TRIF, and TBK1. Association of endogenous TBK1 and Akt was observed in macrophages when stimulated with poly(I:C) and LPS. In vitro kinase assays combined with reversed-phase liquid chromatography mass spectrometry analysis showed that TBK1 enhanced phosphorylation of Akt on Ser(473), whereas knockdown of TBK1 expression by short interfering RNA in macrophages decreased poly(I:C)- and LPS-induced Akt phosphorylation. Embryonic fibroblasts derived from TBK1 knockout mice also showed impaired Akt phosphorylation in response to poly(I:C) and LPS. To our knowledge, our results demonstrate a new regulatory mechanism for Akt activation mediated by TBK1 and a novel role of Akt in TLR-mediated immune responses.
Toll/IL-1R 域包含衔接子诱导 IFN-β(TRIF)是一种衔接子分子,在激动剂刺激下被招募到 TLR3 和 -4,并触发 IFN 调节因子 3(IRF3)和 1 型 IFN 的表达,这对于细胞抗病毒反应至关重要。我们表明 Akt 是 TRIF/TANK 结合激酶 1(TBK1)的下游分子,在 TLR3 和 -4 激动剂激活 IRF3 中发挥重要作用。通过显性负突变体或短发夹 RNA 阻断 Akt 会降低多聚肌苷酸:聚胞苷酸[poly(I:C)]、LPS、TRIF 和 TBK1 诱导的 IRF3 激活和 IFN-β 表达。当用 poly(I:C)和 LPS 刺激巨噬细胞时,观察到内源性 TBK1 和 Akt 之间的关联。体外激酶测定结合反相液相色谱质谱分析表明,TBK1 增强了 Akt 在 Ser(473)上的磷酸化,而巨噬细胞中 TBK1 表达的短发夹 RNA 敲低降低了 poly(I:C)和 LPS 诱导的 Akt 磷酸化。来自 TBK1 敲除小鼠的胚胎成纤维细胞对 poly(I:C)和 LPS 的反应也表现出 Akt 磷酸化受损。据我们所知,我们的结果表明了一种由 TBK1 介导的 Akt 激活的新调节机制,以及 Akt 在 TLR 介导的免疫反应中的新作用。